Abeloff's Clinical Oncology Review E-Book - 5th Edition - ISBN: 9780323222112

Abeloff's Clinical Oncology Review E-Book

5th Edition

Authors: John Niederhuber James Armitage James Doroshow Michael Kastan Joel Tepper
eBook ISBN: 9780323222112
Imprint: Saunders
Published Date: 1st November 2013

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Practical and clinically focused, Abeloff’s Clinical Oncology Review is designed to help you master the latest scientific discoveries and their implications for cancer diagnosis and management in the most accessible manner possible: on your favorite eReader! This new eBook, ideal for fast access and portability, equips you with the core knowledge you need to pass the oncology boards. It's your complete board review package!

Key Features

  • Efficiently review the latest developments in cancer pharmacology, oncology and healthcare policy, survivorship in cancer, and many other timely topics, all in the convenience of an eBook – perfect for study on the go!
  • Quickly and effortlessly access the core, distilled, scientific and clinical oncology know-how you need with key points from Abeloff's famed "Blue Boxes" at the beginning of each chapter.
  • Test your mastery with 500 interactive multiple-choice oncology review questions and answers.
  • Reinforce your knowledge with this ideal review companion to Abeloff's Clinical Oncology, 5th Edition (ISBN: 978-1-4557-2865-7).
  • Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability. Compatible with Kindle®, nook®, and other popular devices.


© Saunders 2014
1st November 2013
eBook ISBN:

About the Author

John Niederhuber

Affiliations and Expertise

Executive Vice President, Inova Health System; CEO and Director, Inova Comprehensive Cancer and Research Institute; CEO Inova Translational Medicine Institute, Falls Church, Virginia; Professor, Oncology and Surgery, The Johns Hopkins University School of Medicine; Deputy Director, Johns Hopkins Clinical Research Network, Baltimore, Maryland

James Armitage

Affiliations and Expertise

Joe Shapiro Professor of Medicine, University of Nebraska Medical Center, Omaha, Nebraska

James Doroshow

Affiliations and Expertise

Bethesda, Maryland

Michael Kastan

Affiliations and Expertise

Executive Director, Duke Cancer Institute; William W. Shingleton Professor, Pharmacology and Cancer Biology, Durham, North Carolina

Joel Tepper

Affiliations and Expertise

Hector MacLean Distinguished Professor of Cancer Research, Department of Radiation Oncology, University of North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina